Market Indices
Sector Heatmap
GLUE — Monte Rosa Therapeutics, Inc. Common Stock
NasdaqMonte Rosa Therapeutics, Inc. Common Stock
- O
- 11.40
- H
- 11.40
- L
- 10.32
- V
- 2.21M
GLUE — Latest News & Headlines
20 StoriesMonte Rosa Therapeutics, Inc. (GLUE) Stock Price, News, Quote & History - Yahoo! Finance Canada
Monte Rosa Therapeutics, Inc. (GLUE) Stock Price, News, Quote & History Yahoo! Finance Canada
$GLUE stock is down 8% today. Here's what we see in our data. - Quiver Quantitative
$GLUE stock is down 8% today. Here's what we see in our data. Quiver Quantitative
BIOA, GLUE Stocks Clock Worst Day In Years— What’s The NVO Connection? - Stocktwits
BIOA, GLUE Stocks Clock Worst Day In Years— What’s The NVO Connection? Stocktwits
Monte Rosa Therapeutics, Inc. (GLUE) stock price, news, quote and history - Yahoo Finance UK
Monte Rosa Therapeutics, Inc. (GLUE) stock price, news, quote and history Yahoo Finance UK
Monte Rosa Therapeutics (NASDAQ:GLUE) Stock Rating Raised to "Strong-Buy" at HC Wainwright - MarketBeat
Monte Rosa Therapeutics (NASDAQ:GLUE) Stock Rating Raised to "Strong-Buy" at HC Wainwright MarketBeat
Monte Rosa Therapeutics Shares Surge Premarket - Monte Rosa Therapeutics (NASDAQ:GLUE) - Benzinga
Monte Rosa Therapeutics Shares Surge Premarket - Monte Rosa Therapeutics (NASDAQ:GLUE) Benzinga
Safety and activity data will be presented Oct. 1 for people at elevated heart-disease risk after four weeks of treatment. - Stock Titan
Safety and activity data will be presented Oct. 1 for people at elevated heart-disease risk after four weeks of treatment. Stock Titan
Monte Rosa Therapeutics Stock In Focus After Phase 1 Data Win - Simply Wall Street
Monte Rosa Therapeutics Stock In Focus After Phase 1 Data Win Simply Wall Street
(GLUE) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
(GLUE) Movement Within Algorithmic Entry Frameworks Stock Traders Daily
Analysts Offer Insights on Healthcare Companies: Monte Rosa Therapeutics (GLUE) and Cullinan Management (CGEM) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Monte Rosa Therapeutics (GLUE) and Cullinan Management (CGEM) The Globe and Mail
Monte Rosa Therapeutics, Inc. $GLUE Shares Newly Acquired by Bank of America Corp DE - MarketBeat
Monte Rosa Therapeutics, Inc. $GLUE Shares Newly Acquired by Bank of America Corp DE MarketBeat
What Monte Rosa Therapeutics (GLUE)'s Phase 2 Trial Start Means For Shareholders - Simply Wall Street
What Monte Rosa Therapeutics (GLUE)'s Phase 2 Trial Start Means For Shareholders Simply Wall Street
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session Benzinga
An experimental drug brought several heart-disease markers to levels seen in healthy volunteers - Stock Titan
An experimental drug brought several heart-disease markers to levels seen in healthy volunteers Stock Titan
Newell Brands Inc. (NWL) Stock Price, News, Quote & History - Yahoo! Finance Canada
Newell Brands Inc. (NWL) Stock Price, News, Quote & History Yahoo! Finance Canada
Monte Rosa Therapeutics (NASDAQ:GLUE) Shares Down 6% - What's Next? - MarketBeat
Monte Rosa Therapeutics (NASDAQ:GLUE) Shares Down 6% - What's Next? MarketBeat
Brokers Set Expectations for GLUE Q3 Earnings - MarketBeat
Brokers Set Expectations for GLUE Q3 Earnings MarketBeat
Tyra Biosciences, Inc. (TYRA) Stock Price, News, Quote & History - Yahoo! Finance Canada
Tyra Biosciences, Inc. (TYRA) Stock Price, News, Quote & History Yahoo! Finance Canada
Monte Rosa Therapeutics (GLUE) Following Phase 1 Data Faces A Big Fair Value Question - Simply Wall Street
Monte Rosa Therapeutics (GLUE) Following Phase 1 Data Faces A Big Fair Value Question Simply Wall Street
Cloudflare (NET) Shares Skyrocket, What You Need To Know - StockStory
Cloudflare (NET) Shares Skyrocket, What You Need To Know StockStory